An open-label phase II trial to evaluate the safety and pharmacokinetics of motexafin gadolinium and cranial irradiation in the treatment of newly diagnosed glioblastoma multiforme.
Phase of Trial: Phase II
Latest Information Update: 03 Feb 2010
At a glance
- Drugs Motexafin gadolinium (Primary)
- Indications Glioblastoma
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Oct 2005 New trial record.